Vanda Surges After Novartis Agrees To Settle Dispute Over Schizop
Shares of Vanda Pharmaceuticals (VNDA) surged as much as 15% in today’s session as Novartis (NVS) has agreed to give the rights of Fanapt, a schizophrenia drug, back to the company. Novartis had high hopes when it first acquired the drug back in 2009 but since then the company has not been happy with its progress. The dispute occurred…